longtext: 5ye7-pdb

content
HEADER    HYDROLASE/HYDROLASE INHIBITOR           15-SEP-17   5YE7
TITLE     THE CRYSTAL STRUCTURE OF LP-PLA2 IN COMPLEX WITH A NOVEL INHIBITOR
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE;
COMPND   3 CHAIN: B, A;
COMPND   4 FRAGMENT: UNP RESIDUES 47-429;
COMPND   5 SYNONYM: LP-PLA2,PAF ACETYLHYDROLASE,1-ALKYL-2-
COMPND   6 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE,2-ACETYL-1-
COMPND   7 ALKYLGLYCEROPHOSPHOCHOLINE ESTERASE,GROUP-VIIA PHOSPHOLIPASE A2,
COMPND   8 GVIIA-PLA2,LDL-ASSOCIATED PHOSPHOLIPASE A2,LDL-PLA(2),PAF 2-
COMPND   9 ACYLHYDROLASE;
COMPND  10 EC: 3.1.1.47;
COMPND  11 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE   3 ORGANISM_COMMON: HUMAN;
SOURCE   4 ORGANISM_TAXID: 9606;
SOURCE   5 GENE: PLA2G7, PAFAH;
SOURCE   6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS    HYDROLASE INHIBITOR, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
EXPDTA    X-RAY DIFFRACTION
AUTHOR    Q.F.LIU,Y.C.XU
REVDAT   1   25-JUL-18 5YE7    0
JRNL        AUTH   Q.LIU,F.HUANG,X.YUAN,K.WANG,Y.ZOU,J.SHEN,Y.XU
JRNL        TITL   STRUCTURE-GUIDED DISCOVERY OF NOVEL, POTENT, AND ORALLY
JRNL        TITL 2 BIOAVAILABLE INHIBITORS OF LIPOPROTEIN-ASSOCIATED
JRNL        TITL 3 PHOSPHOLIPASE A2.
JRNL        REF    J. MED. CHEM.                 V.  60 10231 2017
JRNL        REFN                   ISSN 1520-4804
JRNL        PMID   29193967
JRNL        DOI    10.1021/ACS.JMEDCHEM.7B01530
REMARK   2
REMARK   2 RESOLUTION.    2.31 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : PHENIX (1.11.1_2575: ???)
REMARK   3   AUTHORS     : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN
REMARK   3               : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,
REMARK   3               : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,
REMARK   3               : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,
REMARK   3               : REETAL PAI,RANDY READ,JANE RICHARDSON,
REMARK   3               : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,
REMARK   3               : NICHOLAS SAUTER,JACOB SMITH,LAURENT
REMARK   3               : STORONI,TOM TERWILLIGER,PETER ZWART
REMARK   3
REMARK   3    REFINEMENT TARGET : ML
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 43.87
REMARK   3   MIN(FOBS/SIGMA_FOBS)              : 1.350
REMARK   3   COMPLETENESS FOR RANGE        (%) : 93.5
REMARK   3   NUMBER OF REFLECTIONS             : 34296
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.184
REMARK   3   R VALUE            (WORKING SET) : 0.181
REMARK   3   FREE R VALUE                     : 0.244
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 4.900
REMARK   3   FREE R VALUE TEST SET COUNT      : 1679
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT (IN BINS).
REMARK   3   BIN  RESOLUTION RANGE  COMPL.    NWORK NFREE   RWORK  RFREE
REMARK   3     1 43.8725 -  5.2892    0.99     2972   147  0.1720 0.2092
REMARK   3     2  5.2892 -  4.1993    0.99     2907   141  0.1482 0.2005
REMARK   3     3  4.1993 -  3.6687    0.99     2932   128  0.1567 0.2151
REMARK   3     4  3.6687 -  3.3334    1.00     2919   143  0.1699 0.2175
REMARK   3     5  3.3334 -  3.0946    1.00     2871   150  0.1902 0.2708
REMARK   3     6  3.0946 -  2.9122    1.00     2903   164  0.1986 0.2882
REMARK   3     7  2.9122 -  2.7664    1.00     2881   143  0.2068 0.2892
REMARK   3     8  2.7664 -  2.6459    0.99     2848   172  0.2092 0.2996
REMARK   3     9  2.6459 -  2.5441    0.98     2835   141  0.2213 0.2782
REMARK   3    10  2.5441 -  2.4563    0.92     2637   135  0.2221 0.2821
REMARK   3    11  2.4563 -  2.3795    0.82     2376   120  0.2285 0.3084
REMARK   3    12  2.3795 -  2.3115    0.53     1536    95  0.2375 0.3061
REMARK   3
REMARK   3  BULK SOLVENT MODELLING.
REMARK   3   METHOD USED        : FLAT BULK SOLVENT MODEL
REMARK   3   SOLVENT RADIUS     : 1.11
REMARK   3   SHRINKAGE RADIUS   : 0.90
REMARK   3   K_SOL              : NULL
REMARK   3   B_SOL              : NULL
REMARK   3
REMARK   3  ERROR ESTIMATES.
REMARK   3   COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED)     : 0.300
REMARK   3   PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.010
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 33.45
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 33.50
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : NULL
REMARK   3    B22 (A**2) : NULL
REMARK   3    B33 (A**2) : NULL
REMARK   3    B12 (A**2) : NULL
REMARK   3    B13 (A**2) : NULL
REMARK   3    B23 (A**2) : NULL
REMARK   3
REMARK   3  TWINNING INFORMATION.
REMARK   3   FRACTION: NULL
REMARK   3   OPERATOR: NULL
REMARK   3
REMARK   3  DEVIATIONS FROM IDEAL VALUES.
REMARK   3                 RMSD          COUNT
REMARK   3   BOND      :  0.007           5917
REMARK   3   ANGLE     :  0.884           8034
REMARK   3   CHIRALITY :  0.052            870
REMARK   3   PLANARITY :  0.006           1032
REMARK   3   DIHEDRAL  :  7.776           3444
REMARK   3
REMARK   3  TLS DETAILS
REMARK   3   NUMBER OF TLS GROUPS  : NULL
REMARK   3
REMARK   3  NCS DETAILS
REMARK   3   NUMBER OF NCS GROUPS : NULL
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: NULL
REMARK   4
REMARK   4 5YE7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 26-SEP-17.
REMARK 100 THE DEPOSITION ID IS D_1300005128.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 14-JAN-17
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : 6.6
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : Y
REMARK 200  RADIATION SOURCE               : SSRF
REMARK 200  BEAMLINE                       : BL17U1
REMARK 200  X-RAY GENERATOR MODEL          : NULL
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.9791
REMARK 200  MONOCHROMATOR                  : NULL
REMARK 200  OPTICS                         : NULL
REMARK 200
REMARK 200  DETECTOR TYPE                  : CCD
REMARK 200  DETECTOR MANUFACTURER          : ADSC QUANTUM 315R
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200  DATA SCALING SOFTWARE          : HKL-2000
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 36097
REMARK 200  RESOLUTION RANGE HIGH      (A) : 2.300
REMARK 200  RESOLUTION RANGE LOW       (A) : 50.000
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.7
REMARK 200  DATA REDUNDANCY                : 3.600
REMARK 200  R MERGE                    (I) : 0.16200
REMARK 200  R SYM                      (I) : NULL
REMARK 200   FOR THE DATA SET  : 5.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 2.34
REMARK 200  COMPLETENESS FOR SHELL     (%) : 99.8
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.60
REMARK 200  R MERGE FOR SHELL          (I) : 0.97600
REMARK 200  R SYM FOR SHELL            (I) : NULL
REMARK 200   FOR SHELL         : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: 5I8P
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 49.04
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.41
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MOPS PH 6.6, 0.4M LI2SO4, 27%
REMARK 280  (W/V) (NH4)2SO4, 1M NA-AC, 1.4% 1,4-BUTANEDIOL, VAPOR DIFFUSION,
REMARK 280  HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X,Y,-Z
REMARK 290       3555   X+1/2,Y+1/2,Z
REMARK 290       4555   -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       57.91500
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       41.71300
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       57.91500
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       41.71300
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 14150 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 180 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 14220 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     GLY B    42
REMARK 465     PRO B    43
REMARK 465     LEU B    44
REMARK 465     GLY B    45
REMARK 465     SER B    46
REMARK 465     ALA B    47
REMARK 465     ALA B    48
REMARK 465     ALA B    49
REMARK 465     SER B    50
REMARK 465     PHE B    51
REMARK 465     GLY B    52
REMARK 465     GLN B    53
REMARK 465     THR B    54
REMARK 465     ASN B   423
REMARK 465     THR B   424
REMARK 465     THR B   425
REMARK 465     ASN B   426
REMARK 465     GLN B   427
REMARK 465     HIS B   428
REMARK 465     ILE B   429
REMARK 465     GLY A    42
REMARK 465     PRO A    43
REMARK 465     LEU A    44
REMARK 465     GLY A    45
REMARK 465     SER A    46
REMARK 465     ALA A    47
REMARK 465     ALA A    48
REMARK 465     ALA A    49
REMARK 465     SER A    50
REMARK 465     PHE A    51
REMARK 465     GLY A    52
REMARK 465     GLN A    53
REMARK 465     THR A    54
REMARK 465     ASP A    89
REMARK 465     ASN A    90
REMARK 465     ASP A    91
REMARK 465     ASN A   426
REMARK 465     GLN A   427
REMARK 465     HIS A   428
REMARK 465     ILE A   429
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470   M RES CSSEQI  ATOMS
REMARK 470     LYS B  55    CG   CD   CE   NZ
REMARK 470     GLN B  88    CG   CD   OE1  NE2
REMARK 470     ASP B  89    CG   OD1  OD2
REMARK 470     ASP B  91    CG   OD1  OD2
REMARK 470     LYS B 109    CG   CD   CE   NZ
REMARK 470     HIS B 114    CG   ND1  CD2  CE1  NE2
REMARK 470     TRP B 115    CG   CD1  CD2  NE1  CE2  CE3  CZ2
REMARK 470     TRP B 115    CZ3  CH2
REMARK 470     LEU B 116    CG   CD1  CD2
REMARK 470     LEU B 123    CG   CD1  CD2
REMARK 470     GLU B 142    CG   CD   OE1  OE2
REMARK 470     LYS B 143    CE   NZ
REMARK 470     GLN B 193    CD   OE1  NE2
REMARK 470     LYS B 210    CG   CD   CE   NZ
REMARK 470     GLN B 211    CG   CD   OE1  NE2
REMARK 470     GLU B 212    CG   CD   OE1  OE2
REMARK 470     LYS B 227    CD   CE   NZ
REMARK 470     LYS B 246    CD   CE   NZ
REMARK 470     LYS B 252    CG   CD   CE   NZ
REMARK 470     GLU B 256    CG   CD   OE1  OE2
REMARK 470     ASP B 304    CG   OD1  OD2
REMARK 470     LYS B 363    CG   CD   CE   NZ
REMARK 470     MET B 368    CG   SD   CE
REMARK 470     LYS B 370    CG   CD   CE   NZ
REMARK 470     GLU B 414    CG   CD   OE1  OE2
REMARK 470     LYS A  55    CG   CD   CE   NZ
REMARK 470     ARG A  58    CD   NE   CZ   NH1  NH2
REMARK 470     GLN A  88    CG   CD   OE1  NE2
REMARK 470     ARG A  92    CG   CD   NE   CZ   NH1  NH2
REMARK 470     LEU A  93    CG   CD1  CD2
REMARK 470     LYS A 109    CG   CD   CE   NZ
REMARK 470     HIS A 114    CG   ND1  CD2  CE1  NE2
REMARK 470     TRP A 115    CG   CD1  CD2  NE1  CE2  CE3  CZ2
REMARK 470     TRP A 115    CZ3  CH2
REMARK 470     LEU A 116    CG   CD1  CD2
REMARK 470     MET A 117    CG   SD   CE
REMARK 470     ASN A 133    OD1  ND2
REMARK 470     GLU A 142    CG   CD   OE1  OE2
REMARK 470     LYS A 143    CE   NZ
REMARK 470     GLN A 193    CD   OE1  NE2
REMARK 470     GLU A 197    CG   CD   OE1  OE2
REMARK 470     LYS A 210    CG   CD   CE   NZ
REMARK 470     GLN A 211    CG   CD   OE1  NE2
REMARK 470     GLU A 212    CG   CD   OE1  OE2
REMARK 470     LYS A 227    CD   CE   NZ
REMARK 470     LYS A 246    CD   CE   NZ
REMARK 470     LYS A 252    CG   CD   CE   NZ
REMARK 470     GLU A 256    CG   CD   OE1  OE2
REMARK 470     ASP A 304    CG   OD1  OD2
REMARK 470     GLU A 305    CG   CD   OE1  OE2
REMARK 470     GLU A 340    CG   CD   OE1  OE2
REMARK 470     ARG A 347    CG   CD   NE   CZ   NH1  NH2
REMARK 470     LYS A 363    CG   CD   CE   NZ
REMARK 470     MET A 368    CG   SD   CE
REMARK 470     LYS A 370    CG   CD   CE   NZ
REMARK 470     GLU A 414    CG   CD   OE1  OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    ASN B  90       59.20   -118.17
REMARK 500    LYS B 252       46.77    -74.14
REMARK 500    SER B 273     -113.45     65.93
REMARK 500    HIS B 399       63.65   -105.33
REMARK 500    HIS A 114     -150.04   -100.97
REMARK 500    PRO A 131       71.08    -65.83
REMARK 500    PHE A 156     -169.13   -164.57
REMARK 500    ASP A 250       76.69   -107.99
REMARK 500    LYS A 266       74.18   -112.83
REMARK 500    SER A 273     -117.71     66.01
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 8U0 B 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 502
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 8U0 A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 502
DBREF  5YE7 B   47   429  UNP    Q13093   PAFA_HUMAN      47    429
DBREF  5YE7 A   47   429  UNP    Q13093   PAFA_HUMAN      47    429
SEQADV 5YE7 GLY B   42  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 PRO B   43  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 LEU B   44  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 GLY B   45  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 SER B   46  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 GLY A   42  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 PRO A   43  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 LEU A   44  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 GLY A   45  UNP  Q13093              EXPRESSION TAG
SEQADV 5YE7 SER A   46  UNP  Q13093              EXPRESSION TAG
SEQRES   1 B  388  GLY PRO LEU GLY SER ALA ALA ALA SER PHE GLY GLN THR
SEQRES   2 B  388  LYS ILE PRO ARG GLY ASN GLY PRO TYR SER VAL GLY CYS
SEQRES   3 B  388  THR ASP LEU MET PHE ASP HIS THR ASN LYS GLY THR PHE
SEQRES   4 B  388  LEU ARG LEU TYR TYR PRO SER GLN ASP ASN ASP ARG LEU
SEQRES   5 B  388  ASP THR LEU TRP ILE PRO ASN LYS GLU TYR PHE TRP GLY
SEQRES   6 B  388  LEU SER LYS PHE LEU GLY THR HIS TRP LEU MET GLY ASN
SEQRES   7 B  388  ILE LEU ARG LEU LEU PHE GLY SER MET THR THR PRO ALA
SEQRES   8 B  388  ASN TRP ASN SER PRO LEU ARG PRO GLY GLU LYS TYR PRO
SEQRES   9 B  388  LEU VAL VAL PHE SER HIS GLY LEU GLY ALA PHE ARG THR
SEQRES  10 B  388  LEU TYR SER ALA ILE GLY ILE ASP LEU ALA SER HIS GLY
SEQRES  11 B  388  PHE ILE VAL ALA ALA VAL GLU HIS ARG ASP ARG SER ALA
SEQRES  12 B  388  SER ALA THR TYR TYR PHE LYS ASP GLN SER ALA ALA GLU
SEQRES  13 B  388  ILE GLY ASP LYS SER TRP LEU TYR LEU ARG THR LEU LYS
SEQRES  14 B  388  GLN GLU GLU GLU THR HIS ILE ARG ASN GLU GLN VAL ARG
SEQRES  15 B  388  GLN ARG ALA LYS GLU CYS SER GLN ALA LEU SER LEU ILE
SEQRES  16 B  388  LEU ASP ILE ASP HIS GLY LYS PRO VAL LYS ASN ALA LEU
SEQRES  17 B  388  ASP LEU LYS PHE ASP MET GLU GLN LEU LYS ASP SER ILE
SEQRES  18 B  388  ASP ARG GLU LYS ILE ALA VAL ILE GLY HIS SER PHE GLY
SEQRES  19 B  388  GLY ALA THR VAL ILE GLN THR LEU SER GLU ASP GLN ARG
SEQRES  20 B  388  PHE ARG CYS GLY ILE ALA LEU ASP ALA TRP MET PHE PRO
SEQRES  21 B  388  LEU GLY ASP GLU VAL TYR SER ARG ILE PRO GLN PRO LEU
SEQRES  22 B  388  PHE PHE ILE ASN SER GLU TYR PHE GLN TYR PRO ALA ASN
SEQRES  23 B  388  ILE ILE LYS MET LYS LYS CYS TYR SER PRO ASP LYS GLU
SEQRES  24 B  388  ARG LYS MET ILE THR ILE ARG GLY SER VAL HIS GLN ASN
SEQRES  25 B  388  PHE ALA ASP PHE THR PHE ALA THR GLY LYS ILE ILE GLY
SEQRES  26 B  388  HIS MET LEU LYS LEU LYS GLY ASP ILE ASP SER ASN VAL
SEQRES  27 B  388  ALA ILE ASP LEU SER ASN LYS ALA SER LEU ALA PHE LEU
SEQRES  28 B  388  GLN LYS HIS LEU GLY LEU HIS LYS ASP PHE ASP GLN TRP
SEQRES  29 B  388  ASP CYS LEU ILE GLU GLY ASP ASP GLU ASN LEU ILE PRO
SEQRES  30 B  388  GLY THR ASN ILE ASN THR THR ASN GLN HIS ILE
SEQRES   1 A  388  GLY PRO LEU GLY SER ALA ALA ALA SER PHE GLY GLN THR
SEQRES   2 A  388  LYS ILE PRO ARG GLY ASN GLY PRO TYR SER VAL GLY CYS
SEQRES   3 A  388  THR ASP LEU MET PHE ASP HIS THR ASN LYS GLY THR PHE
SEQRES   4 A  388  LEU ARG LEU TYR TYR PRO SER GLN ASP ASN ASP ARG LEU
SEQRES   5 A  388  ASP THR LEU TRP ILE PRO ASN LYS GLU TYR PHE TRP GLY
SEQRES   6 A  388  LEU SER LYS PHE LEU GLY THR HIS TRP LEU MET GLY ASN
SEQRES   7 A  388  ILE LEU ARG LEU LEU PHE GLY SER MET THR THR PRO ALA
SEQRES   8 A  388  ASN TRP ASN SER PRO LEU ARG PRO GLY GLU LYS TYR PRO
SEQRES   9 A  388  LEU VAL VAL PHE SER HIS GLY LEU GLY ALA PHE ARG THR
SEQRES  10 A  388  LEU TYR SER ALA ILE GLY ILE ASP LEU ALA SER HIS GLY
SEQRES  11 A  388  PHE ILE VAL ALA ALA VAL GLU HIS ARG ASP ARG SER ALA
SEQRES  12 A  388  SER ALA THR TYR TYR PHE LYS ASP GLN SER ALA ALA GLU
SEQRES  13 A  388  ILE GLY ASP LYS SER TRP LEU TYR LEU ARG THR LEU LYS
SEQRES  14 A  388  GLN GLU GLU GLU THR HIS ILE ARG ASN GLU GLN VAL ARG
SEQRES  15 A  388  GLN ARG ALA LYS GLU CYS SER GLN ALA LEU SER LEU ILE
SEQRES  16 A  388  LEU ASP ILE ASP HIS GLY LYS PRO VAL LYS ASN ALA LEU
SEQRES  17 A  388  ASP LEU LYS PHE ASP MET GLU GLN LEU LYS ASP SER ILE
SEQRES  18 A  388  ASP ARG GLU LYS ILE ALA VAL ILE GLY HIS SER PHE GLY
SEQRES  19 A  388  GLY ALA THR VAL ILE GLN THR LEU SER GLU ASP GLN ARG
SEQRES  20 A  388  PHE ARG CYS GLY ILE ALA LEU ASP ALA TRP MET PHE PRO
SEQRES  21 A  388  LEU GLY ASP GLU VAL TYR SER ARG ILE PRO GLN PRO LEU
SEQRES  22 A  388  PHE PHE ILE ASN SER GLU TYR PHE GLN TYR PRO ALA ASN
SEQRES  23 A  388  ILE ILE LYS MET LYS LYS CYS TYR SER PRO ASP LYS GLU
SEQRES  24 A  388  ARG LYS MET ILE THR ILE ARG GLY SER VAL HIS GLN ASN
SEQRES  25 A  388  PHE ALA ASP PHE THR PHE ALA THR GLY LYS ILE ILE GLY
SEQRES  26 A  388  HIS MET LEU LYS LEU LYS GLY ASP ILE ASP SER ASN VAL
SEQRES  27 A  388  ALA ILE ASP LEU SER ASN LYS ALA SER LEU ALA PHE LEU
SEQRES  28 A  388  GLN LYS HIS LEU GLY LEU HIS LYS ASP PHE ASP GLN TRP
SEQRES  29 A  388  ASP CYS LEU ILE GLU GLY ASP ASP GLU ASN LEU ILE PRO
SEQRES  30 A  388  GLY THR ASN ILE ASN THR THR ASN GLN HIS ILE
HET    8U0  B 501      31
HET    SO4  B 502       5
HET    8U0  A 501      31
HET    SO4  A 502       5
HETNAM     8U0 N-[4-[(4-NAPHTHALEN-2-YLOXYPHENYL)
HETNAM   2 8U0  SULFAMOYL]PHENYL]ETHANAMIDE
HETNAM     SO4 SULFATE ION
FORMUL   3  8U0    2(C24 H20 N2 O4 S)
FORMUL   4  SO4    2(O4 S 2-)
FORMUL   7  HOH   *52(H2 O)
HELIX    1 AA1 ASN B  100  GLY B  112  1                                  13
HELIX    2 AA2 HIS B  114  GLY B  126  1                                  13
HELIX    3 AA3 TYR B  160  HIS B  170  1                                  11
HELIX    4 AA4 ASP B  192  GLY B  199  1                                   8
HELIX    5 AA5 LYS B  210  GLU B  212  5                                   3
HELIX    6 AA6 GLU B  213  HIS B  241  1                                  29
HELIX    7 AA7 ASP B  254  LYS B  259  5                                   6
HELIX    8 AA8 SER B  273  ASP B  286  1                                  14
HELIX    9 AA9 VAL B  306  ILE B  310  5                                   5
HELIX   10 AB1 TYR B  324  LYS B  333  1                                  10
HELIX   11 AB2 VAL B  350  ALA B  360  5                                  11
HELIX   12 AB3 GLY B  362  LEU B  369  1                                   8
HELIX   13 AB4 ASP B  376  GLY B  397  1                                  22
HELIX   14 AB5 ASP B  401  GLN B  404  5                                   4
HELIX   15 AB6 TRP B  405  GLU B  410  1                                   6
HELIX   16 AB7 ASN A  100  GLY A  112  1                                  13
HELIX   17 AB8 HIS A  114  GLY A  126  1                                  13
HELIX   18 AB9 TYR A  160  SER A  169  1                                  10
HELIX   19 AC1 ASP A  192  ILE A  198  1                                   7
HELIX   20 AC2 LYS A  210  GLU A  212  5                                   3
HELIX   21 AC3 GLU A  213  HIS A  241  1                                  29
HELIX   22 AC4 ASP A  254  LYS A  259  5                                   6
HELIX   23 AC5 SER A  273  ASP A  286  1                                  14
HELIX   24 AC6 GLY A  303  TYR A  307  5                                   5
HELIX   25 AC7 TYR A  324  CYS A  334  1                                  11
HELIX   26 AC8 VAL A  350  ALA A  360  5                                  11
HELIX   27 AC9 GLY A  362  LEU A  369  1                                   8
HELIX   28 AD1 ASP A  376  GLY A  397  1                                  22
HELIX   29 AD2 ASP A  401  GLN A  404  5                                   4
HELIX   30 AD3 TRP A  405  GLU A  410  1                                   6
SHEET    1 AA110 ASN B 133  TRP B 134  0
SHEET    2 AA110 SER B  64  PHE B  72  1  N  VAL B  65   O  ASN B 133
SHEET    3 AA110 THR B  79  SER B  87 -1  O  TYR B  85   N  GLY B  66
SHEET    4 AA110 ILE B 173  VAL B 177 -1  O  ALA B 176   N  ARG B  82
SHEET    5 AA110 TYR B 144  SER B 150  1  N  PHE B 149   O  ALA B 175
SHEET    6 AA110 ILE B 262  HIS B 272  1  O  ILE B 270   N  VAL B 148
SHEET    7 AA110 CYS B 291  LEU B 295  1  O  LEU B 295   N  GLY B 271
SHEET    8 AA110 LEU B 314  SER B 319  1  O  PHE B 315   N  ALA B 294
SHEET    9 AA110 ARG B 341  ILE B 346  1  O  ILE B 344   N  ASN B 318
SHEET   10 AA110 LEU B 416  PRO B 418 -1  O  ILE B 417   N  THR B 345
SHEET    1 AA2 2 THR B  95  LEU B  96  0
SHEET    2 AA2 2 THR B 129  THR B 130 -1  O  THR B 130   N  THR B  95
SHEET    1 AA3 2 ALA B 186  TYR B 189  0
SHEET    2 AA3 2 SER B 202  TYR B 205 -1  O  LEU B 204   N  THR B 187
SHEET    1 AA410 ASN A 133  TRP A 134  0
SHEET    2 AA410 SER A  64  PHE A  72  1  N  VAL A  65   O  ASN A 133
SHEET    3 AA410 THR A  79  SER A  87 -1  O  TYR A  85   N  GLY A  66
SHEET    4 AA410 ILE A 173  VAL A 177 -1  O  VAL A 174   N  TYR A  84
SHEET    5 AA410 TYR A 144  SER A 150  1  N  VAL A 147   O  ALA A 175
SHEET    6 AA410 ILE A 262  HIS A 272  1  O  ALA A 268   N  LEU A 146
SHEET    7 AA410 CYS A 291  LEU A 295  1  O  LEU A 295   N  GLY A 271
SHEET    8 AA410 LEU A 314  SER A 319  1  O  PHE A 315   N  ALA A 294
SHEET    9 AA410 ARG A 341  ILE A 346  1  O  ILE A 344   N  ASN A 318
SHEET   10 AA410 LEU A 416  PRO A 418 -1  O  ILE A 417   N  THR A 345
SHEET    1 AA5 2 THR A  95  LEU A  96  0
SHEET    2 AA5 2 THR A 129  THR A 130 -1  O  THR A 130   N  THR A  95
SHEET    1 AA6 2 ALA A 186  TYR A 189  0
SHEET    2 AA6 2 SER A 202  TYR A 205 -1  O  LEU A 204   N  THR A 187
CISPEP   1 PHE B   72    ASP B   73          0        -6.59
CISPEP   2 PHE A   72    ASP A   73          0        -3.85
SITE     1 AC1  9 PHE B 110  GLY B 152  LEU B 153  GLY B 154
SITE     2 AC1  9 HIS B 272  SER B 273  GLN B 352  PHE B 357
SITE     3 AC1  9 LEU B 369
SITE     1 AC2  5 ASN A 100  LYS A 101  ARG A 122  ASP B  89
SITE     2 AC2  5 ASN B  90
SITE     1 AC3 10 LEU A 107  PHE A 110  GLY A 152  LEU A 153
SITE     2 AC3 10 GLY A 154  HIS A 272  SER A 273  GLN A 352
SITE     3 AC3 10 PHE A 357  LEU A 371
SITE     1 AC4  7 SER A 308  ARG A 309  ILE A 310  PRO A 311
SITE     2 AC4  7 LYS A 339  HIS B 241  ARG B 264
CRYST1  115.830   83.426   96.760  90.00 114.95  90.00 C 1 2 1       8
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.008633  0.000000  0.004017        0.00000
SCALE2      0.000000  0.011987  0.000000        0.00000
SCALE3      0.000000  0.000000  0.011399        0.00000
TER    2866      ILE B 422
TER    5702      THR A 425
MASTER      369    0    4   30   28    0   10    6 5824    2   72   60
END